世界の活性化部分トロンボプラスチン時間検査（APTT検査）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3755
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、活性化部分トロンボプラスチン時間検査（APTT検査）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（光学技術、機械技術、電気化学技術）、用途別市場規模（ヘパリン療法モニタリング、凝固因子欠損症スクリーニング、凝固阻害剤、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・活性化部分トロンボプラスチン時間検査（APTT検査）の市場動向
・企業の競争状況、市場シェア
・活性化部分トロンボプラスチン時間検査（APTT検査）の種類別市場規模と予測2016-2027（光学技術、機械技術、電気化学技術）
・活性化部分トロンボプラスチン時間検査（APTT検査）の用途別市場規模と予測2016-2027（ヘパリン療法モニタリング、凝固因子欠損症スクリーニング、凝固阻害剤、その他）
・活性化部分トロンボプラスチン時間検査（APTT検査）の北米市場規模2016-2027（アメリカ、カナダ）
・活性化部分トロンボプラスチン時間検査（APTT検査）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・活性化部分トロンボプラスチン時間検査（APTT検査）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・活性化部分トロンボプラスチン時間検査（APTT検査）の中南米市場規模2016-2027（メキシコ、ブラジル）
・活性化部分トロンボプラスチン時間検査（APTT検査）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Medtronic、Abbott、Roche Diagnostics、Siemens Healthineers、Haemonetics、Sysmex、Danaher、Bio-Rad Laboratories、bioMerieux、Eiken Chemical、Life Technologies、Becton, Dickinson and Company）
・結論

Market Analysis and Insights: Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market
The global Activated Partial Thromboplastin Time Testing (APTT Testing) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Activated Partial Thromboplastin Time Testing (APTT Testing) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Activated Partial Thromboplastin Time Testing (APTT Testing) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Activated Partial Thromboplastin Time Testing (APTT Testing) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Activated Partial Thromboplastin Time Testing (APTT Testing) market.

Global Activated Partial Thromboplastin Time Testing (APTT Testing) Scope and Market Size
Activated Partial Thromboplastin Time Testing (APTT Testing) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Activated Partial Thromboplastin Time Testing (APTT Testing) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Optical Technology
Mechanical Technology
Electrochemical Technology

Segment by Application
Heparin Therapy Monitoring
Coagulation Factor Deficiencies Screening
Coagulation Inhibitors
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Medtronic
Abbott
Roche Diagnostics
Siemens Healthineers
Haemonetics
Sysmex
Danaher
Bio-Rad Laboratories
bioMerieux
Eiken Chemical
Life Technologies
Becton, Dickinson and Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Optical Technology
1.2.3 Mechanical Technology
1.2.4 Electrochemical Technology
1.3 Market by Application
1.3.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Heparin Therapy Monitoring
1.3.3 Coagulation Factor Deficiencies Screening
1.3.4 Coagulation Inhibitors
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Perspective (2016-2027)
2.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Growth Trends by Regions
2.2.1 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Share by Regions (2016-2021)
2.2.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Regions (2022-2027)
2.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Industry Dynamic
2.3.1 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Trends
2.3.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Drivers
2.3.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Challenges
2.3.4 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Revenue
3.1.1 Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Revenue (2016-2021)
3.1.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Players (2016-2021)
3.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue
3.4 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Concentration Ratio
3.4.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue in 2020
3.5 Activated Partial Thromboplastin Time Testing (APTT Testing) Key Players Head office and Area Served
3.6 Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Product Solution and Service
3.7 Date of Enter into Activated Partial Thromboplastin Time Testing (APTT Testing) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Activated Partial Thromboplastin Time Testing (APTT Testing) Breakdown Data by Type
4.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Size by Type (2016-2021)
4.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Type (2022-2027)

5 Activated Partial Thromboplastin Time Testing (APTT Testing) Breakdown Data by Application
5.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Size by Application (2016-2021)
5.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
6.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
6.2.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
6.2.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
6.2.3 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
6.3 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
6.3.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
6.3.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
6.3.3 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
6.4 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
6.4.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
6.4.2 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
7.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
7.2.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
7.2.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
7.2.3 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
7.3 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
7.3.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
7.3.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
7.3.3 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
7.4 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
7.4.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
7.4.2 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
8.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
8.2.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
8.3 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
8.3.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
8.4 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region
8.4.1 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
9.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
9.2.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
9.2.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
9.2.3 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
9.3 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
9.3.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
9.3.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
9.3.3 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
9.4 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
9.4.1 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
9.4.2 Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2016-2027)
10.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type
10.2.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2027)
10.3 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application
10.3.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2027)
10.4 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country
10.4.1 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.1.4 Medtronic Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.2.4 Abbott Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.3.4 Roche Diagnostics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.3.5 Roche Diagnostics Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.4.4 Siemens Healthineers Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.4.5 Siemens Healthineers Recent Development
11.5 Haemonetics
11.5.1 Haemonetics Company Details
11.5.2 Haemonetics Business Overview
11.5.3 Haemonetics Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.5.4 Haemonetics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.5.5 Haemonetics Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Details
11.6.2 Sysmex Business Overview
11.6.3 Sysmex Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.6.4 Sysmex Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.6.5 Sysmex Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.7.4 Danaher Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.7.5 Danaher Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.8.4 Bio-Rad Laboratories Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 bioMerieux
11.9.1 bioMerieux Company Details
11.9.2 bioMerieux Business Overview
11.9.3 bioMerieux Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.9.4 bioMerieux Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.9.5 bioMerieux Recent Development
11.10 Eiken Chemical
11.10.1 Eiken Chemical Company Details
11.10.2 Eiken Chemical Business Overview
11.10.3 Eiken Chemical Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.10.4 Eiken Chemical Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.10.5 Eiken Chemical Recent Development
11.11 Life Technologies
11.11.1 Life Technologies Company Details
11.11.2 Life Technologies Business Overview
11.11.3 Life Technologies Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.11.4 Life Technologies Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.11.5 Life Technologies Recent Development
11.12 Becton, Dickinson and Company
11.12.1 Becton, Dickinson and Company Company Details
11.12.2 Becton, Dickinson and Company Business Overview
11.12.3 Becton, Dickinson and Company Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
11.12.4 Becton, Dickinson and Company Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
11.12.5 Becton, Dickinson and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Optical Technology
Table 3. Key Players of Mechanical Technology
Table 4. Key Players of Electrochemical Technology
Table 5. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions (2016-2021)
Table 9. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions (2022-2027)
Table 11. Activated Partial Thromboplastin Time Testing (APTT Testing) Market Trends
Table 12. Activated Partial Thromboplastin Time Testing (APTT Testing) Market Drivers
Table 13. Activated Partial Thromboplastin Time Testing (APTT Testing) Market Challenges
Table 14. Activated Partial Thromboplastin Time Testing (APTT Testing) Market Restraints
Table 15. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Players (2016-2021)
Table 17. Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) as of 2020)
Table 18. Ranking of Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Product Solution and Service
Table 22. Date of Enter into Activated Partial Thromboplastin Time Testing (APTT Testing) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Type (2016-2021)
Table 26. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Application (2016-2021)
Table 30. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Medtronic Company Details
Table 63. Medtronic Business Overview
Table 64. Medtronic Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 65. Medtronic Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 66. Medtronic Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 70. Abbott Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Roche Diagnostics Company Details
Table 73. Roche Diagnostics Business Overview
Table 74. Roche Diagnostics Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 75. Roche Diagnostics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 76. Roche Diagnostics Recent Development
Table 77. Siemens Healthineers Company Details
Table 78. Siemens Healthineers Business Overview
Table 79. Siemens Healthineers Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 80. Siemens Healthineers Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 81. Siemens Healthineers Recent Development
Table 82. Haemonetics Company Details
Table 83. Haemonetics Business Overview
Table 84. Haemonetics Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 85. Haemonetics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 86. Haemonetics Recent Development
Table 87. Sysmex Company Details
Table 88. Sysmex Business Overview
Table 89. Sysmex Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 90. Sysmex Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 91. Sysmex Recent Development
Table 92. Danaher Company Details
Table 93. Danaher Business Overview
Table 94. Danaher Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 95. Danaher Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 96. Danaher Recent Development
Table 97. Bio-Rad Laboratories Company Details
Table 98. Bio-Rad Laboratories Business Overview
Table 99. Bio-Rad Laboratories Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 100. Bio-Rad Laboratories Recent Development
Table 101. bioMerieux Company Details
Table 102. bioMerieux Business Overview
Table 103. bioMerieux Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 104. bioMerieux Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 105. bioMerieux Recent Development
Table 106. Eiken Chemical Company Details
Table 107. Eiken Chemical Business Overview
Table 108. Eiken Chemical Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 109. Eiken Chemical Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 110. Eiken Chemical Recent Development
Table 111. Life Technologies Company Details
Table 112. Life Technologies Business Overview
Table 113. Life Technologies Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 114. Life Technologies Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 115. Life Technologies Recent Development
Table 116. Becton, Dickinson and Company Company Details
Table 117. Becton, Dickinson and Company Business Overview
Table 118. Becton, Dickinson and Company Activated Partial Thromboplastin Time Testing (APTT Testing) Product
Table 119. Becton, Dickinson and Company Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021) & (US$ Million)
Table 120. Becton, Dickinson and Company Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type: 2020 VS 2027
Figure 2. Optical Technology Features
Figure 3. Mechanical Technology Features
Figure 4. Electrochemical Technology Features
Figure 5. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application: 2020 VS 2027
Figure 6. Heparin Therapy Monitoring Case Studies
Figure 7. Coagulation Factor Deficiencies Screening Case Studies
Figure 8. Coagulation Inhibitors Case Studies
Figure 9. Others Case Studies
Figure 10. Activated Partial Thromboplastin Time Testing (APTT Testing) Report Years Considered
Figure 11. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions: 2020 VS 2027
Figure 14. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions (2022-2027)
Figure 15. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Players in 2020
Figure 16. Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue in 2020
Figure 18. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Type (2016-2021)
Figure 19. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Type (2022-2027)
Figure 20. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2016-2027)
Figure 22. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2016-2027)
Figure 23. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Country (2016-2027)
Figure 24. United States Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2016-2027)
Figure 28. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2016-2027)
Figure 29. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Country (2016-2027)
Figure 30. Germany Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Region (2016-2027)
Figure 40. China Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2016-2027)
Figure 48. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2016-2027)
Figure 49. Latin America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Country (2016-2027)
Figure 50. Mexico Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Country (2016-2027)
Figure 56. Turkey Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Medtronic Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 61. Roche Diagnostics Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 62. Siemens Healthineers Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 63. Haemonetics Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 64. Sysmex Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 65. Danaher Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 66. Bio-Rad Laboratories Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 67. bioMerieux Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 68. Eiken Chemical Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 69. Life Technologies Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 70. Becton, Dickinson and Company Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Global Activated Partial Thromboplastin Test Market Size, Status and Forecast 2021-2027
QFJ1-3754 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、活性化部分トロンボプラスチン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（光学技術試験、機械技術試験、電気化学技術試験）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリ...

世界のデジタルPCR＆リアルタイムPCR（qPCR）市場規模・現状・予測（2021年-2027年）

Global Digital PCR and Real-time PCR(qPCR) Market Size, Status and Forecast 2021-2027
QFJ1-5150 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、デジタルPCR＆リアルタイムPCR（qPCR）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬）、用途別市場規模（腫瘍学、血液検査、病原体検出、研究、法医学）、主要地域別市場規模（北米、アメ...

世界のプロトロンビン時間検査市場規模・現状・予測（2021年-2027年）

Global Prothrombin Time Testing Market Size, Status and Forecast 2021-2027
QFJ1-4781 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、プロトロンビン時間検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機械技術試験、電気化学技術試験、光学技術試験、その他）、用途別市場規模（病院、在宅医療設備、診断研究所、その他）、主要地域別市場規...

世界の消費者用遺伝子検査（DTC）市場規模・現状・予測（2021年-2027年）

Global Genetic Testing for Consumers (DTC) Market Size, Status and Forecast 2021-2027
QFJ1-4253 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、消費者用遺伝子検査（DTC）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キャリア検査、予測検査、祖先＆関係検査、ニュートリゲノミクス検査、その他）、用途別市場規模（オンラインプラットフォーム、店頭...

世界の自動車用試験・検査・認証（TIC）市場規模・現状・予測（2021年-2027年）

Global Automotive Testing, Inspection and certification (TIC) Market Size, Status and Forecast 2021-2027
QFJ1-2156 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、自動車用試験・検査・認証（TIC）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（社内、外注）、用途別市場規模（テレマティクス、認証試験、車検サービス、電気システムおよびコンポーネント、燃料、流体およ...

世界のプロテイナーゼ活性化受容体2市場規模・現状・予測（2021年-2027年）

Global Proteinase Activated Receptor 2 Market Size, Status and Forecast 2021-2027
QFJ1-5971 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、プロテイナーゼ活性化受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酢酸ララゾチド、AZ-8838、PZ-235、P-2pal18S、その他）、用途別市場規模（アトピー性皮膚炎、セリアック病、...

世界のエンテレグ（アルビモパン）市場規模・現状・予測（2021年-2027年）

Global Entereg (alvimopan) Market Size, Status and Forecast 2021-2027
QFJ1-5724 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、エンテレグ（アルビモパン）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12mgカプセル、タイプII）、用途別市場規模（腸部分切除、根治的膀胱切除術）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のPCR＆リアルタイムPCR分子診断市場規模・現状・予測（2021年-2027年）

Global PCR and Real-time PCR Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-5292 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、PCR＆リアルタイムPCR分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（器具、試薬、消耗品）、用途別市場規模（感染症検査、腫瘍検査、遺伝子検査、その他）、主要地域別市場規模（北米、アメリカ、...

世界の海洋生物除去（MGR）市場規模・現状・予測（2021年-2027年）

Global Marine Growth Removal (MGR) Market Size, Status and Forecast 2021-2027
QFJ1-2244 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、海洋生物除去（MGR）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（電動工具、手工具）、用途別市場規模（海底建設、船体洗浄、係留システム洗浄、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の蛍光活性化セルソーティング市場規模・現状・予測（2021年-2027年）

Global Fluorescence Activated Cell Sorting Market Size, Status and Forecast 2021-2027
QFJ1-4230 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、蛍光活性化セルソーティングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（がん、AIDS）、用途別市場規模（病院、クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の活性化部分トロンボプラスチン検査市場規模・現状・予測（2021年-2027年） Activated Partial Thromboplastin Test is mainly used to measure coagulation cascade i.e. blood clotting which is mainly derived from the original form of test in which only phospholipids concentration of test was controlled. Market Analysis and Insights: Global Activated Partial Thromboplastin Test …
世界のプロトロンビン時間検査市場規模・現状・予測（2021年-2027年） Prothrombin time (PT) is a blood test which is used to assess the time required to clot a blood. This test is useful to detect and diagnose various bleeding and excessive clotting disorder and also used to monitor the efficacy of various anticoagulant. Market Analysis and Insights: Global Prothrombi…
世界の止血及び凝固分析器産業調査2019-2025 A hemostasis analyzer can analyze compromised icteric, hemolytic, and lipemic samples in as little as 3 minutes.The Hemostasis and Coagulation Analyzer market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this s…
世界の止血及び凝固分析器産業調査2019-2025 A hemostasis analyzer can analyze compromised icteric, hemolytic, and lipemic samples in as little as 3 minutes.The Hemostasis and Coagulation Analyzer market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this s…
世界の獣医におけるヘモグロビンA1C検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hemoglobin A1C Testing in Veterinary Market The global Hemoglobin A1C Testing in Veterinary market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…